PASSAGE BIO, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-56.3M | $158.9M |
| FY2020 | — | $304.7M | $135.0M |
| FY2021 | — | $318.7M | $129.0M |
| FY2022 | — | $201.4M | $34.6M |
| FY2023 | — | $111.3M | $21.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-56.3M | $158.9M |
| FY2020 | — | $304.7M | $135.0M |
| FY2021 | — | $318.7M | $129.0M |
| FY2022 | — | $201.4M | $34.6M |
| FY2023 | — | $111.3M | $21.7M |